ID Connect to Share Key Insights and Data at IDWeek 2024 - Infectious Disease Connect ID Connect to Share Key Insights and Data at IDWeek 2024 - Infectious Disease Connect

Events,News

ID Connect to Share Key Insights and Data at IDWeek 2024

As a leader in telemedicine-enabled infectious disease care, antimicrobial stewardship, and infection prevention and control, Infectious Disease Connect is excited to share valuable insights at IDWeek™ 2024. This premier event, gathering over 10,000 attendees, will take place from October 16-19, 2024, in Los Angeles, CA. We look forward to connecting with fellow leaders in infectious diseases.

Speakers and topics include:

Rima Abdel Massih, M.D.
President & Chief Executive Officer

ID Telehealth Cases: Do’s And Don’ts for Different Telecare Modalities

Moderator

ID Physician Compensation Update: It’s About Time (and Value)

Panelist

Quality/Outcome Based Incentives: The Road to Value

Speaker


Matthew Davis, PharmD
Director of Infectious Diseases Pharmacy Services

Implementation and outcomes of a fully remote tele-ID and tele-OPAT program at a regional medical center

 Infectious Diseases Pharmacist Curbsides: Questions Infectious Diseases Providers Ask Infectious Diseases Pharmacists

Should Paucity Give Us Pause? Revisiting Data Behind Common Practices in Infectious Diseases

SIDP Annual Meeting presenter


Nupur Gupta

Nupur Gupta, DO, MPH
Infectious Diseases Specialist

Lead Author

Seema Mehta Steinke, M.D., M.S.
Infectious Diseases Specialist

Poster Presenter

Observational Comparison of In-Person vs. Remote Care for Bone and Joint Infections


profile photo of Erin McCreary

Erin K. McCreary, PharmD, BCPS, BCIDP
Director of Stewardship Innovation, Infectious Disease Connect; Director of Infectious Diseases Improvement and Clinical Research Innovation, UPMC; Clinical Assistant Professor of Medicine, University of Pittsburgh

Best Practices in Antimicrobial Stewardship Programs ($)

Beyond the 101: Pondering Perplexing Prescribing Issues

Population Pharmacokinetics of Meropenem-Vaborbactam in Acutely Ill Hospitalized Patients with Various Degrees of Renal Dysfunction

Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

Co-Author


Diana Zhong, M.D., MHS
Infectious Diseases Specialist

Out-BREAK! – an ID Escape Room

Co-creator and organizer


IDWeek uniquely unites infectious diseases clinicians, investigators, and infection preventionists to explore current developments in the field of Infectious Diseases (ID). Sponsored by the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists, this annual meeting bridges the fields of real-world ID clinical practice and research.

You might also like…

Infectious Disease Connect and UNM SRMC Release Groundbreaking White Paper on Telemedicine’s Impact on Infectious Disease Care

ID Connect Named “Telehealth Company to Know” by Becker’s Hospital Review

How a Comprehensive Telemedicine Service Model Can Cover an Entire Health Network

Receive Your Copy of IDC’s Information

Please fill out the form below to access this content.

Thank you, the form submit was successful!